Care

Julie Frey, VP of product at Wolters Kluwer Health, discusses how the company's clinical decision support tool, which combines trusted evidence with generative AI, fits into clinical workflows and augments physicians' judgment.

The company will use the funds to drive commercial growth, broaden its employer and payer programs, and accelerate AI development.

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital health technology can do."

The package of bills aims to bolster protections for children using online chatbots, including prohibiting chatbots from representing themselves as healthcare professionals.

The company offers a patient recruitment platform for clinical trials.

Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.

Dr. Hassan Tetteh of the Johns Hopkins Center for Digital Health and AI says that agentic AI has the potential to surpass human intelligence and change the way we work, but can also enable personalized, more patient-driven healthcare.

The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.

The funds will be used to expand operations and attract new partners.

The company received an additional equity investment from OrbiMed.